THE IMPACT OF RAD6 EXPRESSION ON CHEMORESISTANT OVARIAN CANCER: A SYSTEMATIC REVIEW
Chemotherapy is one of the modalities for treating ovarian cancer (OC), which is one of the most common reproductive organ cancers in women worldwide. Overexpression of RAD6 has been identified as a significant factor in chemoresistance in ovarian cancer patients. This systematic review aims to eval...
Saved in:
| Main Authors: | Leo Vernadesly, Nita Hertati, Pariyana |
|---|---|
| Format: | Article |
| Language: | Indonesian |
| Published: |
Universitas Sriwijaya
2025-01-01
|
| Series: | Jurnal Kedokteran dan Kesehatan |
| Subjects: | |
| Online Access: | https://jkk-fk.ejournal.unsri.ac.id/index.php/jkk/article/view/477 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ascitis as a unique microenvironment of tumors in ovarian cancer: interaction with prognosis and chemoresistance
by: A. B. Villert, et al.
Published: (2019-07-01) -
SPL-108 mitigates metastasis and chemoresistance in tubo-ovarian carcinoma
by: Olivia D. Lara, et al.
Published: (2025-01-01) -
Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer
by: Michal M Hoppe, et al.
Published: (2021-03-01) -
Novel gene rearrangement leads to altered expression of Hornerin in sensitive and chemoresistant ovarian cancer
by: Ghassan M. Saed, et al.
Published: (2025-11-01) -
To Help the Practitioner: Imaging of Ovarian Masses According to the O-RADS MRI Ovarian Malignancy Categorical Risk Scale
by: S. P. Aksenova, et al.
Published: (2023-11-01)